Home | CIGB-247 vaccine in patients with solid malignant tumors, phase I, randomized. (CENTAURO-2 study)
Published clinical_trials CIGB-247 vaccine in patients with solid malignant tumors, phase I, randomized. (CENTAURO-2 study) has only one revision
RevisionStatus
Saved 23/06/2013 - 2:12am by admincurrent revision (published)
Equipo de Trabajo del RPCEC | CENCEC - MINSAP
rpcec@cencec.sld.cu
Calle 5ta A Edificio CECMED-CENCEC 2do piso e/ 60 y 62 Miramar, Playa.CP 11300. La Habana, Cuba
Telef: (537) 216-4126 | (537) 216-4212 | (537) 216-4218.
Copyright © 2014-2022 All Rights Reserved.